LEIDOS BIOMEDICAL RESEARCH INC - MD NET
Key Details
Description
MD NET
Context & Analysis
On Feb 20, 2026, Department of Health and Human Services obligated $163,472,364 to LEIDOS BIOMEDICAL RESEARCH INC for md net. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in FREDERICK, MD. The contract is scheduled through Sep 29, 2028. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.
Market context
- Recompete outlook
- Ends Sep 29, 2028, in 23 months. Recompete signal as of Oct 25, 2026: 50/100, combining time to the end date, the incumbent's history with this agency, whether the award was competed, and its size.
- Competition
- Competed. 85% of 511 awards in this market (Department of Health and Human Services awards in NAICS 541715 over the last 3 years) were competed; median 2 offers.
- Award size
- At $163.5M, this award is larger than 19 in 20 of the 541 priced Department of Health and Human Services awards in NAICS 541715 over the last 3 years (median $1.5M).
- Incumbent at this agency
- LEIDOS BIOMEDICAL RESEARCH INC has 69 other awards from Department of Health and Human Services, totalling $2.6B, 2016–2026.
- Largest vendors in this market
By obligations, Department of Health and Human Services awards in NAICS 541715 over the last 3 years.
- LEIDOS HOLDINGS, INC. — 59 awards, $2.3B
- THE MITRE CORPORATION — 40 awards, $315.7M
- WESTAT, INC. — 11 awards, $222.2M
- BATTELLE MEMORIAL INSTITUTE — 3 awards, $121.5M
- DUKE UNIVERSITY — 16 awards, $117.6M
Computed from USAspending award data on Oct 25, 2026.
Contractor Information
Similar Awards
NCI OPERATIONAL TASK ORDER, FY26-FY27
LEIDOS BIOMEDICAL RESEARCH INC
$826.0M
NCI OPERATIONAL TASK ORDER, FY26-FY27
LEIDOS BIOMEDICAL RESEARCH INC
$327.1M
NIAID COVID-19 ACTIV3
LEIDOS BIOMEDICAL RESEARCH INC
$159.1M
ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)
LEIDOS BIOMEDICAL RESEARCH INC
$141.7M
NIAID DCR FY26-27 OPERATIONAL TASK ORDER
LEIDOS BIOMEDICAL RESEARCH INC
$137.7M
Stay Updated
Get notified about new opportunities matching your interests.